As we said earlier in the year, given the investment and restructuring in the US, we expect an H2 weighting in FY16. As indicated at the update in July, sales are slightly behind last year but efficiencies and cost savings mean that operating performance is ahead. Given the modest half year loss, the dividend has been passed, but the balance sheet remains strong with net cash now expected to reach $5.0m by the year end. The H2 pipeline is stronger than H1 and, although conditions remain competitive and project timing is difficult to gauge, we retain our full year P&L forecasts.